World Cancer Leaders' Summit 2025
Bridging Divides, Building Futures | Melbourne, Australia, 18-20 November 2025
Guided tours at WCLS 2025
Peter MacCallum Cancer Centre
Don’t miss the opportunity for a guided tour and networking opportunity at Peter MacCallum Cancer Centre (Peter Mac).
As a world leading cancer research, education and treatment centre Peter Mac provides specialised, multidisciplinary care for those with cancer, inclusive of the most rare and complex cases. As the only publicly funded Comprehensive Cancer Centre in Australia, Peter Mac’s approach is driven by the relentless pursuit of excellence and a deeply embedded culture of innovation.
For over 75 years, Peter Mac has pursued better treatments, high quality care and potential cures for cancer. We are the largest cancer research site in Australia, with more than 700 laboratory and clinical researchers, nurses, and support staff working to advance cancer research and care. Our clinically directed, preclinical and clinical R&D program fast tracks the translation and commercialisation of our discoveries. Peter Mac’s researchers collectively publish more than 1000 journal articles annually - nearly a quarter of them in high-impact-journals.
A bus will depart from the Pan Pacific Hotel at 1:00 pm and return to the same location at 4:30 pm at the latest.
-
The tour is limited to 50 participants.
-
Registration is free of charge but it is only available for participants who are already registered for the World Cancer Leaders' Summit.
-
Registration will be granted on a first-come, first-served basis.
-
Given the limited number of seats, please only register if you are sure to attend.
The Australian Centre for the Prevention of Cervical Cancer (ACPCC)
The Australian Centre for the Prevention of Cervical Cancer (ACPCC) is home to the Australian HPV Reference Laboratory, listed by WHO as an HPV Performance Evaluation Laboratory. ACPCC is recognised for its leading role in Australia’s National Cervical Screening Program (NCSP) and its contribution to global cervical cancer elimination efforts.
During this exclusive tour, delegates will:
- See a wide range of commercially available HPV assays on multiple validated instruments, all of which have been fully validated for cervical cancer screening and used in Australia’s NCSP.
- Explore point-of-care testing platforms that can be utilised in remote or resource-limited settings, expanding access to timely and accurate results across diverse populations.
Delegates will also discover ACPCC’s role in supporting companies with expert advice and guidance on the production of numerous quality control materials for HPV assays, as well as its active involvement in HPV test evaluations and support with laboratory strengthening in partner countries as part of the Elimination Partnership for Cervical Cancer in the Indo-Pacific (EPICC).
This visit will provide valuable insight into how these innovations are integrated into screening programs of very different scales and resource availability.
Delegates will also have the opportunity to discuss future collaboration, all with the shared goal of accelerating the elimination of cervical cancer and strengthening cancer control efforts globally.
The maximum capacity for tours is 12. ACPCC is located at 265 Faraday St, Carlton, Vic, 3053.
- The tour is limited to 12 participants.
- Registration is free of charge but it is only available for participants who are already registered for the World Cancer Leaders' Summit.
- Registration will be granted on a first-come, first-served basis.
- Given the limited number of seats, please only register if you are sure to attend.
The Monash Partners Comprehensive Cancer Consortium (MPCCC)
The Monash Partners Comprehensive Cancer Consortium (MPCCC) is honoured to welcome delegates from the Union for International Cancer Control (UICC) on Tuesday, 18 November 2025, for an engaging discussion and exchange of ideas.
This visit will offer delegates the opportunity to connect with leaders in cancer research, care, and collaboration across Victoria. The afternoon will focus on conversation, reflection, and shared learning about MPCCC's unique decentralised model of cancer care and our role in driving innovation and equity across the state.
The session will open with a formal welcome from Professor Christina Mitchell AO, Executive Dean of the Faculty of Medicine, Nursing and Health Sciences at Monash University, followed by a short video showcasing collaborative achievements and patient impact.
Delegates will then hear a series of ‘spotlight stories’ - brief, high-impact talks from clinical leaders, researchers, and patient advocates, illustrating how decentralised care models translate into real-world improvements. A facilitated discussion and Q&A will follow, allowing participants to exchange ideas and explore opportunities for international collaboration.
The afternoon will conclude with reflections and an interactive activity, encouraging delegates to share insights and takeaways from their time with MPCCC.
Afternoon tea will be provided.
- The tour is limited to 50 participants.
- Registration is free of charge but it is only available for participants who are already registered for the World Cancer Leaders' Summit.
- Registration will be granted on a first-come, first-served basis.
- Given the limited number of seats, please only register if you are sure to attend.